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Cytomegalovirus (CMV) disease with a high incidence of mortality is a serious
complication in leukemia patients who receive 7 irradiation to eradicate leu-
kemic cells and continued immunosuppressive treatment after bone marrow
transplantation to depress graft-vs.-host disease (1). The infection of the trans-
plant recipient can be primary, transferred with the transplant as infectious virus
or in the form of latently infected cells, or can result from reactivation of latent
virus genome harbored in tissues of the recipient. In either case, the immuno-
compromised state is decisive for the spread of virus and the manifestation of
disease with destruction of target tissues. Recently, it became evident that man-
ifestations of CMV disease are frequent and often represent the final reason for
mortality in patients with AIDS (2-4). Interstitial pneumonia is assumed to be
the cause of death from human CMV disease, although other organs are also
severely affected.
Experimental evidence for the cause of death can be attained only in an ani-
mal model. For studying CMV pathogenesis and protective immunity, we use the
infection o£ mice with murine CMV (MCMV)' as a model system (5-9). Under
the experimental conditions chosen, the immunocompetent host can control the
infection, while the immunodepleted host succumbs to viral disease manifested
by histopathology in various organs including the lungs, where interstitial pneu-
monia could be demonstrated (9). Protection against MCMV disease is mediated
by virus-specific T lymphocytes of the CD8+ subset (9-12). Among the multi-
tude of proteins specified by MCMV, the nonstructural immediate-early protein
pp89 (13, 14) encoded by gene ieI (15, 16) was identified as an immunodomi-
nant antigen recognized by CTL (17-22) and responsible for the induction of
protective immunity (22a).
The definition of the most critical target tissues for viral infection is essential
for selective antiviral therapy. We had observed previously that lethally infected
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mice that survived after adoptive immunocytotherapy established a long-lasting
persistent infection, some individuals of which showed considerable virus repli-
cation in the lungs 2 mo after lymphocyte transfer without signs of morbidity
(11) . This finding already raised doubt of whether interstitial pneumonia alone
is responsible for mortality. We present evidence that failure in hemopoiesis is
the primary cause of death from CMV disease in the murine model system.
Materials and Methods
Dual-parameter Light Scatter Analysis of Bone Marrow Cells.
￿
Suspensions of bone mar-
row cells were obtained by flushing PBS supplemented with 5% FCS through the shafts
of the femori and tibiae. The pooled cells yielded from two femori and two tibiae were
taken as representative of the bone marrow. Suspensions were passed through nylon
mesh to remove clumps, and were enriched for mononuclear bone marrow cells by
removing most of the erythrocytes and granulocytes during a density gradient centrifu-
gation (30 min at 800 g) using Lymphoprep (Nyegaard, Oslo, Norway) for separation.
In normal BALB/c mice (8-wk-old females, MHC haplotype H-2d), the average yield was
5 X 107 bone marrow cells. At day 14 after irradiation (6 Gy) and infection, the average
yield of bone marrow cells was reduced to 2 X 105.
The dual-parameter light scatter analysis was performed on FACS IV (Becton Dickin-
son FACS Systems, Sunnyvale, CA) measuring 50,000 cells per analysis with a flow rate
of 2,000 cells/s. Right angle (90°) light scatter and forward (3°) light scatter, representing
granularity and size, respectively, were expressed on scales of 64 channels. Three-dimen-
sional images of light scatter profiles were obtained by connecting the cell frequency
peaks of all net points in the 64 X 64 channel matrix normalized to the peak of the
highest cell frequency (computer program provided by M . Blaurock, Medical University
Clinic, Tubingen, Federal Republic of Germany).
Bone Marrow Transplantation and Adoptive T Lymphocyte Transfer.
￿
To serve as recipi-
ents of bone marrow or of effector T lymphocytes, 8-wk-old female BALB/c mice were
subjected to total-body y irradiation with a single radiation dose of 6 Gy by using a
cesium-137 source, delivering a dose rate of 1 .325 Gy/min. After irradiation, mice were
kept under laminar flow. For intraplantar infection, 105 plaque-forming units of MCMV
(strain Smith, VR-194; American Type Culture Collection, Rockville, MD) were injected
into the left hind footpad 2 h before cell transfer. Morbidity caused by irradiation alone
was indicated by hunching, wasting, and a bleeder symptom resulting from thrombocy-
topenia. Superimposed intraplantar infection caused hemorrhages spreading from the
site of infection and necroses in internal organs including the lungs, spleen, liver, and
adrenal glands (9, 12).
For bone marrow transplantation, bone marrow cells from normal syngeneic donors
(8-12-wk-old female BALB/c mice) were isolated as described above except that granu-
locytes and erythrocytes were not removed. Mature T lymphocytes contained in the bone
marrow cell suspension were eliminated by treatment with mAb anti-Lyt-2.2 (anti-CD8)
and mAb anti-L3T4 (anti-CD4) as described previously (9). The purified bone marrow
cells were infused intravenously. Syngeneic antiviral effector T lymphocytes were gener-
ated and separated into CD4+ and CD8+ subpopulations as detailed in a previous report
(11), and were infused accordingly.
Assays for the Determination of Hemopoietic Stem Cells and Progenitors.
￿
For the determi-
nation of hemopoiesic stem cells (CFU-S), bone marrow cells were isolated without deple-
tion of cell populations, and graded numbers were transferred intravenously into irra-
diated (7.5 Gy), noninfected recipients. The radiation dose of 7.5 Gy was chosen to
exclude the formation of endogenous spleen colonies in the recipients. This condition
was fulfilled (see Fig. 3 C). At day 14 after transfer, the spleens of six recipients per bone
marrow cell dose were fixed in Bouin's solution, and surface colonies, each representing
the progeny of a single stem cell, were counted (23, 24) . Only late colonies present
beyond day 10 after transfer are derived from multipotential, self-generating stem cells,
whereas transient early colonies visible at day 7 or 8 (CFU-S-II) contain terminally dif-MUTTER ET AL.
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ferentiating erythroid cells (25, 26). According to Metcalf (27) the term CFU-S-I is used
for stem cells that form late colonies. The number of CFU-S-I per donor bone marrow
was calculated from the number of spleen colonies counted in the linear portion of the
titration (see Fig. 3 C) by multiplication with the yield of bone marrow cells. The data
were not corrected for the fraction of stem cells that reach the spleen after transfer. For
bone marrow cells derived from noninfected mice, this fraction has been found to be
0.17 (24).
For the quantitation of the progenitors of the granulocyte/monocyte lineage, the
CFU-GM, mononuclear bone marrow cells were enriched by Lymphoprep separation,
and 5 X 104 cells were dispensed in 1 ml of semi-solid Iscove's Modified Dulbecco's
Medium (074-2200; Gibco Laboratories, Grand Island, NY) containing 0.9% wt/vol
methylcellulose, 20% FCS, and 5% WEHI 3B-conditioned medium as a source of multi-
potential CSF (28). Granulocyte/monocyte colonies were counted after 8 d of incubation
(5% C01, 37°C, humidified atmosphere).
Determination of Virus Titers in Tissues.
￿
Infectious MCMV in lungs, spleen, and adre-
nal glands was quantitated 14 d after infection by a plaque assay as described before (9).
The detection limit was 100 plaque-forming units of MCMV per organ homogenate. Sets
of virus titers are regarded as significantly different for P < a = 0.05 (one-sided), where
P denotes the observed probability value, and a denotes the selected significance level
(Wilcoxon-Mann-Whitney exact rank sum test).
In Vivo Assay for the Detection of Infected Bone Marrow Cells.
￿
For an in vivo limiting
dilution analysis of infected cells, bone marrow cells were isolated from irradiated (6 Gy),
infected mice without depletion of cell populations, and were separated from free virus
by centrifugation through an FCS cushion. Graded numbers were transferred intrave-
nously into irradiated (6 Gy) recipients. At day 14 after cell transfer, inoculation of the
lungs was scored positive or negative by measuring the virus titer. The frequency (f) of
infected cells in the transferred cell population was estimated by the Maximum Likeli-
hood method (29) .
By transfer of limiting numbers (8-0.5 in two-fold dilutions) of infected mouse embryo
fibroblasts, a cell type that is permissive for productive MCMV infection, this in vivo
assay was found to be sensitive enough to detect a single productively infected cell (f =
1/1 .2, P = 0 .24).
Results
MCMV Infection Prevents Autoreconstitution of Bone Marrow.
￿
Sublethal total-
body y irradiation with a radiation dose of 6 Gy depresses the immune defense
of BALB/c mice to an extent that infection with MCMV leads to lethal disease
(9). This radiation dose does not eliminate all bone marrow stem cells and,
therefore, the bone marrow should be replenished by hemopoiesis.
To test whether or not hemopoiesis is affected during murine CMV disease,
the autoreconstitution of bone marrow was monitored in irradiated vs. irradi-
ated and infected animals by means of dual-parameter light scatter analysis of
bone marrow cells. The assay is explained in Fig. 1 with an analysis of normal
bone marrow serving as a standard for comparison.
2 d after irradiation, the bone marrow was found to be almost depleted of
nucleated cells. Autoreconstitution was visible at day 6 as an emerging peak of
cells that assumed the shape of normal bone marrow by day 14 (Fig. 2, left col-
umn) . After irradiation and infection (Fig. 2, right column), hemopoiesis initially
generated new bone marrow cells, but this autoreconstitution discontinued
around day 6 with the final result that infected animals were practically devoid
of bone marrow cells by day 10 after infection. It should be recollected that day
6 and 14 after infection have been defined before as set-points in murine CMV1648
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FIGURE 1 .
￿
Dual-parameter light scatter anal-
ysis of normal bone marrow cells . (Top) Two-
dimensional display of right-angle (90°) vs. for-
ward (3 ° ) light scatter . The contour lines rep-
resent levels of 2, 4, 8, 16, 32, 64, and 128
cells with a total of 50,000 Lymphoprep-puri-
Fed bone marrow cells analyzed. The arrows
point to areas in the contour plot where the
indicated cell populations are known to be
located . (Bottom) Three-dimensional image of
the same analysis showing the cell frequencies
in the third dimension .
disease after irradiation . By day 6, virus has colonized target tissues, such as the
lungs, and at day 14 mortality is at its summit (9). Thus, inhibition of hemo-
poiesis becomes effective at the time when infection is established in host tissues,
and mortality coincides with a state of almost complete bone marrow depletion.
MCMV Infection Interferes with the Earliest Step in Hemopoiesis .
￿
So far, the data
have shown that infection inhibits autoreconstitution already at an early stage of
disease, at a time when virus multiplication in permissive tissues has just begun
(9) . If the depletion of bone marrow observed after day 6 after infection is
caused by direct infection of many bone marrow cells, this would indicate a par-
ticular tropism ofMCMV for bone marrow . The number of infected cells detect-
able in the bone marrow during the critical time period between day 4 and 8
after infection was, however, very low . This result applied to productively
infected cells enumerated by the in vivo titration of bone marrow cells in irra-
diated recipients (Table 1) as well as to the total number of infected cells esti-
mated by dot blot hybridization using cloned genomic fragments of MCMV
DNA (not shown) . Thus, neither direct elimination of many cells by productive,
cytolytic infection nor direct functional inactivation of many cells by nonpro-
ductive or latent infection can account for the observed depletion of bone mar-
row . Rather, it has to be proposed that infection has an effect upon the gener-
ation of bone marrow cells from a few stem cells or progenitors .
This idea was supported by quantifying two types of hemopoietic cells (Fig .
3) . After irradiation alone, the number of CFU-GM, the progenitors of mono-
cytes and granulocytes, exponentially increased with time indicating successful
autoreconstitution (Fig . 3 A, closed circles), while after irradiation and infection
the number of CFU-GM remained stationary on a low level (Fig . 3 A, open cir-FIGURE: 2 . CMV infection prevents auto-
reconstitution of bone marrow in the irra-
diated host . (Left column) Kinetics of bone
marrow autoreconstitution after total-body
.y irradiation with a radiation dose of 6 Gy,
visualized by dual-parameter light scatter
analysis of bone marrow cells . (Right col-
umn) Kinetics of bone marrow autorecon-
stitution after irradiation and intraplantar
infection with MCMV . Five individuals per
group and per time point were analyzed
and ranked according to increasing prog-
ress in bone marrow autoreconstitution .
For the sake of brevity, the bone marrow
profiles are depicted only for the animals
with the median (No . 3) rank .
cles) . This finding explains the granulocytopenia observed as one symptom of
CMV disease in the mouse (30) . It has to be considered, however, that a block
in only one differentiation lineage cannot account for the observed almost com-
plete failure in autoreconstitution (Fig. 2) . Since all types of progenitors arise
from a multipotential stem cell pool, it was reasonable to ask whether the stag-
TABLE I
Frequency of Infected Cells in the Bone Marrow
Days after
￿
Proportion of infected recipients*
MUTTER ET AL .
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infection
￿
0.5 X 105 BMC
￿
2 X 10 5 BMC
￿
S X 10 5 BMC
￿
Frequency
4 ND 0/12 0/12 =
8
￿
0/14 1/14 8/14 1/1,150,000
11
￿
7/14 11/14 14/14 1/100,000
* At the indicated times after infection, bone marrow cells (BMC) were collected
from irradiated, infected mice and pooled. For the enumeration of infected
cells, graded numbers of BMC were transfused intravenously into irradiated
recipient mice . The fractions represent the proportion of recipients that scorea
positive for infection of the lungs .
" No frequency estimate possible .1650
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FIGURE 3.
￿
Failure in the generation of hemopoietic progenitors and stem cells. (A and B)
Kinetics of the generation of CFU-GM (A) and CFU-S-I (B) during autoreconstitution after
irradiation alone (closed circles) or after irradiation and infection (open circles). Data represent
the mean numbers of colonies from three individuals tested separately (A) or the average
numbers of colonies determined for bone marrow cells pooled from an adequate number of
donor mice (B), both calculated per bone marrow. (C) The determination of the CFU-S-I
contained at day 10 after infection in the bone marrow of irradiated, infected mice (arrow in
B) is resolved to greater detail . The absolute count of spleen surface colonies is depicted as
a function of the number of transplanted bone marrow cells (BMC). The open circles rep-
resent measurements in six individual recipients.
nation in CFU-GM generation could be traced back to a depletion of stem cells
or to a failure in the differentiation of stem cells to lineage progenitors. The
self-generating, multipotential blast colony-forming cells CFU-S-I represent the
earliest stem cells for which an assay is available, namely the formation of clon-
ally derived cell colonies in the spleen of lethally irradiated bone marrow recip-
ients (23-2'7) . It was found that infection prevents the proliferation already of
the CFU-S-I (Fig. 3 B) . It is worth noting that a low number of CFU-S-I could
be isolated from the bone marrow at all tested times after infection (Fig. 3 B,
open circles). To show convincingly that these CFU-S-I were derived from the
infected donor and not by autoreconstitution in the recipients used for detec-
tion, the determination at day 10 (Fig. 3 B, arrow) is resolved to greater detail
by depicting the absolute count of spleen surface colonies as a function of the
number of transferred donor bone marrow cells (Fig. 3 Q. Thus, although in
the donor bone marrow the number of CFU-S-1 remained stationary, these
CFU-S-I could proliferate and form colonies when translocated to recipient
spleens. This fact argues against eradication of CFU-S-I by direct infection. Alto-
gether, the findings allow the conclusion that MCMV infection interferes with
the earliest detectable step in hemopoiesis, the generation of CFU-S-I.
Postulates for Proving a Proposed Vital Importance of Bone Marrow Autoreconsti-
tution. An obvious question to be answered is whether the observed virus-
mediated failure in hemopoiesis plays an essential part in lethal disease. If oneMUITER ET AL .
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is to propose that not the histopathology observed in important tissues, e.g.,
interstitial pneumonia, hepatitis, and adrenalitis, but the depletion of bone mar-
row, is the primary cause of death, two conditions must be fulfilled for confir-
mation . First, as it is known that adoptive transfer of virus-specific CD8+ T lym-
phocytes limits virus multiplication, prevents tissue destruction, and mediates
survival (9-12), these cells must also restore the autoreconstitution by defeating
the antihemopoietic effect of infection . Second, bone marrow transplantation
should mediate survival notwithstanding continued virus multiplication in other
tissues.
Adoptive Transfer ofCD8+ TLymphocytes Restores Autoreconstitution of Bone Mar-
row. CD8+ T lymphocytes, but not CD4+ T lymphocytes, prevent histopathol-
ogy by an antiviral function (11) . However, this fact did not allow predictions
concerning the roles ofT lymphocyte subsets in preventing the failure in hem-
opoiesis . CD8+ T lymphocytes could control virus multiplication by their anti-
viral function, while CD4+ T lymphocytes could restore hemopoiesis by produc-
ing hemopoietic lymphokines . This possibility had to be tested (Fig . 4) .
Short-term lines of virus-specific T lymphocytes propagated in IL-2 without
feeder cells were depleted of either subset, and graded numbers of CD8+ or
CD4+ T lymphocytes were transferred at the day of infection . The purity of the
transferredT lymphocyte subsets was controlled by cytofluorometric analysis as
documented in a previous report (11) . In addition, the absence of hemopoietic
stem cells in both preparations was ascertained by the absence of spleen colonies
after transfer into lethally irradiated (7.5 Gy), noninfected recipients (not
shown) . The bone marrow of the sublethally irradiated (6 Gy), infected recipi-
ents was analyzed at day 14 after infection and T lymphocyte transfer (Fig. 4) .
Already, after transfer of only 104 CD8+ T lymphocytes, an effect was visible,
and the degree of autoreconstitution improved with increasing doses of protec-
FIGURE 4 .
￿
Effect of T lym-
phocyte transfer on bone
marrow autoreconstitution .
Antiviral T lymphocytes iso-
lated from draining popliteal
lymph nodes of immunocom-
petent donors 8 d after intra-
plantar infection with MCMV
were propagated in vitro for a
further 8 d with rIL-2 and
were then depleted of either
subset (11) . Graded numbers
of purified CD8+ or CD4+ T
lymphocytes were transferred
intravenously into irradiated,
infected recipients . After 14
d, the success of bone mar-
row autoreconstitution was
controlled by dual-parameter
light scatter analysis . Of five
individuals tested per group,
the bone marrow profile of
the one with the median virus
titer in the lungs (see Fig. 5)
is depicted.1652
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tive lymphocytes, leading to almost normal bone marrow when 106 CD8+ T lym-
phocytes were transferred (Fig. 4 a-c). CD4+ T lymphocytes had no effect, not
even at the highest cell number tested (Fig. 4 d), as was the case also with non-
specific T lymphocytes activated by IL-2 in vitro (not included in Fig. 4) . In
conclusion, the same T lymphocyte subset that controls virus multiplication and
mediates survival also facilitates bone marrow autoreconstitution.
Syngeneic Bone Marrow Transplantation Has No Effect on the Virus Multiplication
in Host Tissues. For the same individuals whose bone marrow autoreconstitu-
tion was studied (Fig. 4), virus titers in the lungs, spleen, and adrenal glands are
depicted in Fig. 5. It is apparent that low virus titers in tissues correspond with
successful autoreconstitution of bone marrow.
One reasonable explanation for this observation is that a direct antiviral func-
tion of CD8+ T lymphocytes is responsible for both effects. So far, however, the
data were also consistent with the interpretation that the only direct in vivo
function of CD8+ T lymphocytes was to restore hemopoiesis, and that newly
arisingbone marrow cells did control infection. This idea was formally disproved
by the demonstration that syngeneic bone marrow cells did not exert an antiviral
effect within the test period (Fig. 5; compare groups A and D, p > 0.1 in all
tissues). In conclusion, bone marrow transplantation does not affect the repli-
cation of MCMV in host tissues, and the control of virus replication is mediated
by a direct antiviral function of CD8+ T lymphocytes.
Transfer of CD8+ TLymphocytes and Syngeneic Bone Marrow Transplantation Both
Mediate Survival. The second prediction of the working hypothesis was that
bone marrow cells alone should prevent death, despite their inability to limit
MCMV multiplication in host tissues.
Irradiated, infected mice died of MCMV disease without exception between
day 10 and 20 after infection (Fig. 6, open squares). Mortality set in when the
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FIGURE 5. Antiviral efficacy
of T lymphocyte subsets and
bone marrow cells. Virus
titers in tissues were mea-
sured at day 14 after infec-
tion in five recipients per
group. Individual titers are
signified by closed circles, and
median values are marked by
horizontal bars. The dashed
line represents the detection
level. (A) No transfer of lym-
phocytes. (B,, B2, B3)Transfer
of 104, 105, and 106 CD8+ T
lymphocytes, respectively. (C)
Transfer of 106 CD4+ T lym-
phocytes. (D) Transfer of 106
bone marrow cells depleted
of T lymphocytes. The indi-
viduals in group B,, B2, B3,
and C with the median virus
titers in the lungs are those
whose bone marrow profiles
are shown in Fig. 4 a, b, c, and
d, respectively.MUTTER ET AL.
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FIGURE 6. Antiviral CD8+ T lymphocytes and
bone marrow cells both protect against lethal
CMVdisease. Mortalityin 20 irradiated (6 Gy),
infected recipients per group (n = 20) was
monitored for 30 d after no transfer of cells
(open squares), transfer of 106 bone marrow
cells depleted of Tlymphocytes (closed squares),
transfer of 106 CD4+ T lymphocytes (open cir-
cles), and transfer of 106 CD8+ T lymphocytes
(closed circles).
bone marrow was depleted of cells and when virus multiplication caused nec-
roses in organs that are of vital importance, e.g., the lungs, liver, and adrenal
glands. Adoptive transfer of CD4+ T lymphocytes did not cure either symptom
(Figs. 4 and 5) and, accordingly, all recipients died of disease (Fig. 6, open cir-
cles). Adoptive transfer of CD8 + T lymphocytes cured both symptoms. Accord-
ingly, recipients survived (Fig. 6, closed circles), and it was not possible to judge
whether bone marrow autoreconstitution or prevention of histopathology was
more important. The decision came from the transfer of bone marrow cells.
Although bone marrow cells did not limit virus multiplication in tissues, all
recipients survived (Fig. 6, closed squares).
In three repeated experiments, which were all performed with 20 animals per
group, the mortality was always 100% after no transfer of cells or after transfer
of CD4 + T lymphocytes. After transfer of bone marrow cells, the survival rate
was 90-100%, whereas after transfer of CD8+ T lymphocytes, the survival rate
ranged from 45 to 95%. This range reflects the variance in the survival
rate observed after 6 Gy irradiation without infection (not shown). It has been
discussed in a previous report (11) that CD8+ T lymphocytes cannot remedy
radiation sickness but can only prevent the adverse effects of additional
infection.
In essence, mice that did not possess bone marrow cells during a critical phase
of disease around day 10 after infection died (Fig. 6, open symbols), while bone
marrow reconstituted mice survived (closed symbols), regardless of whether or not
virus multiplication in tissues was controlled by antiviral effector cells. We there-
fore conclude that aplasia resulting from the virus-induced failure in hemo-
poiesis is the primary cause of death from CMV disease in the immunocom-
promised murine host.
Discussion
Recent findings have indicated a similarity in the pathogenesis of murine and
human CMV also with regard to an effect on hemopoiesis. During MCMV dis-
ease, granulocytopenia and thrombocytopenia were observed (30, 31) and, like-1654
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wise, a failure in thrombocytopoiesis has also been diagnosed in patients with
opportunistic human CMV infection (32). It has been reported that human early
hemopoietic cells can be infected with human CMV in vitro (33). The spleen
colony-forming assay that defines the multipotential stem cell CFU-S-I is not
feasible in humans, and consequently, nothing is known of the human equivalent
of CFU-S-I. At this point of investigation, only a model system can provide fur-
ther insight into the causes of malfunction.
Our findings demonstrate for MCMV disease and predict for human CMV
disease that CMV infection interferes with the generation already of the earliest
detectable stem cell in hemopoiesis, the CFU-S-I.
It is of interest to know the mechanism by which CMV inhibits the generation
of CFU-S-I as well as the mechanism by which CD8+ T lymphocytes prevent that
inhibition. A final answer to these questions is beyond the scope of our present
contribution, but apparent possibilities might be discussed.
First, virus could eliminate CFU-S-I by direct infection. Two observations
argue against that mechanism. (a) A low but significant number of CFU-S-I
could be demonstrated at all tested times after infection in the bone marrow of
irradiated, infected hosts. Although the number of infected cells detectable in
the bone marrow increased tenfold between day 8 and 11 after infection, the
number of residual CFU-S-I did not decrease, suggesting that CFU-S-I did not
serve as targets for MCMV. (b) Transfer of normal bone marrow cells into
infected recipients led to the development of CFU-S-I colonies in spleens (not
shown), where at the same time, virus was replicating. Moreover, the reconsti-
tution with bone marrow was successful in irradiated, infected mice as all recip-
ients survived. These findings showed that stem cells are not eradicated in the
bone marrow of infected mice and that after adoptive transfer, the remaining
CFU-S-I can proliferate at least in the environment of the spleen.
Second, the proliferation of CFU-S-I in the bone marrow could be discontin-
ued by cessation of the production of essential growth-promoting cytokines. To
date, the only cytokine supposed to promote the generation of CFU-S-I is the
lymphokine IL-3 (synonym: multi-CSF) produced mainly by activated T lympho-
cytes of the CD4+ subset (28, 34). Our finding that activated CD4+ T lympho-
cytes did not restore hemopoiesis does not exclude the explanation that a defi-
ciency in IL-3 is responsible for the failure in hemopoiesis, as we do not know
whether adoptively transferred CD4+ T lymphocytes secrete IL-3 at the site
where it is needed. One should also consider that the generation of CFU-S-I in
autoreconstituting bone marrow after sublethal irradiation does certainly not
depend upon IL-3 produced by antigen-activated T lymphocytes. The regulation
of CFU-S-1 proliferation must rather be either autocrine or mediated by a cyto-
kine delivered by a radiation (6 Gy)-resistant stroma cell.
Third, impairment of the stromal microenvironment could account for the
failure in stem cell proliferation. The hemopoietic microenvironment of the
bone marrow stroma consists of endothelial cells and a network of fibroblasts,
macrophages, and adipocytes (for review see reference 35). It is known that
stroma cells play a critical role in hemopoiesis by promoting maintenance and
self-renewal of CFU-S-I (36), and it has been shown recently that fibroblastoid
adventitial reticular cells of the stroma support hemopoiesis (37) . Several col-MUITER ET AL.
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ony-stimulating cytokines are secreted by stroma-derived cell lines (38-41). In
this context it is important to recollect that murine CMV productively infects
fibroblasts in vitro (42) and in vivo (9). The observation that CFU-S-I that
remained resting in the bone marrow of the infected host could form colonies
when translocated by adoptive transfer into the spleen (recapitulate Fig. 3 B and
Q suggests an influence of the hemopoietic microenvironment on the genera-
tion of CFU-S-I.
It is known from clinical experience that (a) mainly recipients of allogeneic
bone marrow, but not recipients of syngeneic bone marrow, develop severe
CMV disease, although the incidence of CMV infection is similar in both groups
of patients (1), and that (b) recovery from CMV infection correlates with the
presence of CMV-specific CTL (4). Our finding that an important function of
CTL is to prevent the antihemopoietic effect of CMV infection discloses a com-
mon protective principle of syngeneic bone marrow transplantation and antiviral
cellular immunity, namely the replenishment of bone marrow by reconstitution
and autoreconstitution, respectively. Thus, the murine model system offers an
explanation for the clinical observations.
We postulate that the high incidence of lethal CMV disease in recipients of
allogeneic bone marrow is the result of an ineffective reconstitution by histoin-
compatible hemopoietic cells. An incomplete or delayed generation of immune
effector cells then leads to a failure in the control of disease. The antihemo-
poietic effect of CMV infection has the same consequence. Thus, a synergism in
the effects of histoincompatibility and CMV infection could explain the associ-
ation between graft-vs.-host disease and fatal CMV disease.
Summary
We have shown in a murine model system for cytomegalovirus (CMV) disease
in the immunocompromised host that CMV infection interferes with the earliest
detectable step in hemopoiesis, the generation of the stem cell CFU-S-1, and
thereby prevents the autoreconstitution of bone marrow after sublethal irradia-
tion. The antihemopoietic effect could not be ascribed to a direct infection of
stem cells. The failure in hemopoiesis was prevented by adoptive transfer of anti-
viral CD8 + T lymphocytes and could be overcome by syngeneic bone marrow
transplantation. CD8 + T lymphocytes and bone marrow cells both mediated sur-
vival, although only CD8 + T lymphocytes were able to limit virus multiplication
in host tissues. We concluded that not the cytopathic effect of virus replication
in host tissues, but the failure in hemopoiesis, is the primary cause of death in
murine CMV disease.
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